Furthermore, other factors may alter PD-L1 expression in BCC and, therefore, possibly its response to IT, as a recent study found that arsenic exposure changed levels of PD-L1 expression in BCC patients [54]. This evidence concerns the gene CD274 and skin basal cell carcinoma.